Gambia summary indicators
| Baseline costing indicators | 2001 |
| GDP per capita1 | $290 |
| Population2 | $1,388,452 |
| Surviving infants2 | 46,000 |
| DTP-3 coverage3 | 90% |
| Total health expenditure per capita (Current $)4 | $18.5 |
| Total spending on routine immunization5 | $1,547,737 |
| - per DTP-3 immunized child | $37.4 |
| - per capita | $1.11 |
| - as a % of overall health expenditure | 6.0% |
| Total spending on the NIP (including campaigns)5 | $1,867,536 |
| - as a % of overall health expenditure | 7.3% |
| Future resource requirements, financing and gaps5 | 2003-2006 |
| Avg. annual resource requirements | $1,822,790 |
| - % new-underused vaccines | 44.3% |
| - per DTP-3 targeted child | $30.2 |
| Avg. annual secure funding | $1,232,665 |
| - % from government | 7.6% |
| - % from GAVI-Vaccine Fund | 71.2% |
| - % from other donors | 21.2% |
| Avg. annual probable funding | $590,125 |
| Avg. annual funding gap (secure and probable funding) | $0 |
| - % of resource requirements | 0.0% |
| - per DTP-3 targeted child | $0.0 |
Sources:
- World Development Indicators - World Bank for GDP
- United Nations Population Division, Department of Economic and Social Affairs, World Population Prospects the 2002 Revisions
- WHO-UNICEF Coverage Best Estimates
- WHO - World Health Report 2003
- Immunization Financing Database. Immunization specific spending is reported.